Reirradiation of primary brain tumours: survival, clinical response and prognostic factors.

Veninga, T; Langendijk, H A; Slotman, B J; Rutten, E H; van der Kogel, A J; Prick, M J; Keyser, A; van der Maazen, R W

Veninga, T; Langendijk, H A; Slotman, B J; Rutten, E H; van der Kogel, A J; Prick, M J; Keyser, A; van der Maazen, R W.

Affiliation

Veninga T; Department of Radiation Oncology, RADIAN, Joint Centre for Radiation Oncology Arnhem-Nijmegen, University Hospital Nijmegen, P.O. Box 9101, 6500 HB, The, Nijmegen, Netherlands.

Radiother Oncol ; 59(2): 127-37, 2001 May.

Article in En | MEDLINE | ID: mdl-11325440

Subject(s)

Brain Neoplasms/radiotherapy; Cranial Irradiation; Neoplasm Recurrence, Local/radiotherapy; Adrenal Cortex Hormones/therapeutic use; Adult; Brain Neoplasms/drug therapy; Brain Neoplasms/mortality; Female; Humans; Male; Multivariate Analysis; Neoplasm Recurrence, Local/mortality; Prognosis; Proportional Hazards Models; Quality of Life; Radiotherapy Dosage; Survival Analysis; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Brain Neoplasms / Cranial Irradiation / Neoplasm Recurrence, Local Type of study: Prognostic_studies Limits: Adult / Female / Humans / Male Language: En Journal: Radiother Oncol Year: 2001 Type: Article Affiliation country: Netherlands

Search on Google

Add to My VHL

XML

PubMed Links